Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Capital Expenditures: 2024-2025

Historic Capital Expenditures for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $97,000.

  • CG Oncology's Capital Expenditures rose 9800.00% to $97,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $336,000, marking a year-over-year change of. This contributed to the annual value of $234,000 for FY2024, which is N/A change from last year.
  • Per CG Oncology's latest filing, its Capital Expenditures stood at $97,000 for Q3 2025, which was up 592.86% from $14,000 recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Capital Expenditures ranged from a high of $209,000 in Q4 2024 and a low of -$1,000 during Q3 2024.
  • Its 2-year average for Capital Expenditures is $51,571, with a median of $14,000 in 2025.
  • Data for CG Oncology's Capital Expenditures shows a peak YoY skyrocketed of 9,800.00% (in 2025) over the last 5 years.
  • Over the past 2 years, CG Oncology's Capital Expenditures (Quarterly) stood at $209,000 in 2024, then soared by 9,800.00% to $97,000 in 2025.
  • Its Capital Expenditures was $97,000 in Q3 2025, compared to $14,000 in Q2 2025 and $16,000 in Q1 2025.